| Title |
Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2005
|
| DOI | 10.1002/14651858.cd004583.pub2 |
| Pubmed ID | |
| Authors |
Valery L Feigin, Neil Anderson, Gabriel JE Rinkel, Ale Algra, Jan van Gijn, Derrick A Bennett |
| Abstract |
Corticosteroids, particularly dexamethasone, are commonly used for treatments in patients with subarachnoid haemorrhage (SAH) and primary intracerebral haemorrhage (PICH) despite the lack of evidence. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Brazil | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | <1% |
| Brazil | 1 | <1% |
| Sweden | 1 | <1% |
| United Kingdom | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 146 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 16% |
| Researcher | 21 | 14% |
| Other | 15 | 10% |
| Student > Doctoral Student | 14 | 9% |
| Student > Ph. D. Student | 13 | 9% |
| Other | 38 | 25% |
| Unknown | 26 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 46% |
| Neuroscience | 19 | 13% |
| Nursing and Health Professions | 10 | 7% |
| Psychology | 4 | 3% |
| Agricultural and Biological Sciences | 2 | 1% |
| Other | 10 | 7% |
| Unknown | 36 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2022.
All research outputs
#13,565,040
of 22,994,508 outputs
Outputs from Cochrane database of systematic reviews
#10,136
of 12,348 outputs
Outputs of similar age
#49,929
of 57,584 outputs
Outputs of similar age from Cochrane database of systematic reviews
#30
of 35 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,348 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.6. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,584 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.